Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIKE-1 Trial: Camostat for prevention of COVID-19 respiratory deterioration
2020-002110-41Phase 2Unknown
- Sponsor
- Cancer Research UK
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of camostat mesilate in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Cancer Research UK. Primary endpoint: Primary: Hospital admission requiring supplemental oxygen. Status: unknown.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002110-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002110-41.